Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial.
Lancet Haematol. 2024 Mar;11(3):e216-e227. doi: 10.1016/S2352-3026(24)00005-X.
Lancet Haematol. 2024.
PMID: 38423700
Clinical Trial.
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.
Wang M, Siddiqi T, Gordon LI, Kamdar M, Lunning M, Hirayama AV, Abramson JS, Arnason J, Ghosh N, Mehta A, Andreadis C, Solomon SR, Kostic A, Dehner C, Espinola R, Peng L, Ogasawara K, Chattin A, Eliason L, Palomba ML.
Wang M, et al. Among authors: eliason l.
J Clin Oncol. 2024 Apr 1;42(10):1146-1157. doi: 10.1200/JCO.23.02214. Epub 2023 Dec 10.
J Clin Oncol. 2024.
PMID: 38072625
Clinical Trial.
Item in Clipboard
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
Popat R, Lonial S, Voorhees PM, Esposti SD, Gorsh B, Gupta I, Opalinska J, Sapra S, Piontek T, He Z, Kleinman D, Schaumberg D, Regnault A, Meunier J, Eliason L.
Popat R, et al. Among authors: eliason l.
J Adv Pract Oncol. 2023 Sep;14(6):503-518. doi: 10.6004/jadpro.2023.14.6.4. Epub 2023 Sep 1.
J Adv Pract Oncol. 2023.
PMID: 37808071
Free PMC article.
Item in Clipboard
A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies.
Regnault A, Loubert A, Gorsh B, Davis R, Cardellino A, Creel K, Quéré S, Sapra S, Nelsen L, Eliason L.
Regnault A, et al. Among authors: eliason l.
J Natl Cancer Inst. 2023 May 8;115(5):586-596. doi: 10.1093/jnci/djad018.
J Natl Cancer Inst. 2023.
PMID: 36715639
Free PMC article.
Item in Clipboard
Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma.
Eliason L, Grant L, Francis A, Cardellino A, Culver K, Chawla SP, Arbuckle R, Pokras S.
Eliason L, et al.
J Patient Rep Outcomes. 2022 May 4;6(1):43. doi: 10.1186/s41687-022-00450-1.
J Patient Rep Outcomes. 2022.
PMID: 35507231
Free PMC article.
Item in Clipboard
Cite
Cite